XEIA Venture Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Coherence Neurocoherenceneuro.comin𝕏Nov 2025 · $10M
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in
Co-investorsArtesianBlackbird VenturesPossible VenturesSmartGateVCDivergent CapitalSciFounders+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.